Загрузка...
Iron Chelation Therapy in Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous disorder of the hematopoietic stem cells, frequently characterized by anemia and transfusion dependency. In low-risk patients, transfusion dependency can be long lasting, leading to iron overload. Iron chelation therapy may be a therapeutic option...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2905902/ https://ncbi.nlm.nih.gov/pubmed/20672005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/756289 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|